| 4.09 0.08 (2%) | 10-23 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.24  |
1-year : | 6.12 |
| Resists | First : | 4.48 |
Second : | 5.24 |
| Pivot price | 4.09 |
|||
| Supports | First : | 3.93 |
Second : | 3.59 |
| MAs | MA(5) : | 4.07  |
MA(20) : | 4 |
| MA(100) : | 4.53 |
MA(250) : | 5.56 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 44.8 |
D(3) : | 51.3 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 11 | Low : | 3.59 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NNOX ] has closed above bottom band by 49.0%. Bollinger Bands are 26.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.13 - 4.15 | 4.15 - 4.18 |
| Low: | 3.93 - 3.96 | 3.96 - 3.99 |
| Close: | 4.05 - 4.09 | 4.09 - 4.13 |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Thu, 23 Oct 2025
NANO-X IMAGING LTD (NNOX) Stock Analysis: Potential Upside of 93% Amidst Growing Healthcare Innovation - DirectorsTalk Interviews
Thu, 16 Oct 2025
NANO-X IMAGING LTD (NNOX) Stock Analysis: Unveiling a 77% Potential Upside in the Healthcare Imaging Sector - DirectorsTalk Interviews
Thu, 18 Sep 2025
Nanox Announces Multi-Segment Healthcare Collaboration with - GlobeNewswire
Fri, 05 Sep 2025
Daniel Ran, CFO of Nano-X Imaging, buys $3650 in NNOX shares - Investing.com
Sun, 31 Aug 2025
Nano-X Imaging Earnings Call: Mixed Outlook with Strategic Progress - TipRanks
Wed, 13 Aug 2025
Nano-X Imaging: Still No Opportunity Here (NASDAQ:NNOX) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 64 (M) |
| Shares Float | 61 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 20.8 (%) |
| Shares Short | 6,540 (K) |
| Shares Short P.Month | 6,790 (K) |
| EPS | -0.9 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.55 |
| Profit Margin | 0 % |
| Operating Margin | -475.6 % |
| Return on Assets (ttm) | -19 % |
| Return on Equity (ttm) | -32.9 % |
| Qtrly Rev. Growth | 12.6 % |
| Gross Profit (p.s.) | -0.19 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.72 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -38 (M) |
| Levered Free Cash Flow | -21 (M) |
| PE Ratio | -4.55 |
| PEG Ratio | 0 |
| Price to Book value | 1.59 |
| Price to Sales | 21.99 |
| Price to Cash Flow | -6.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|